Dossiers d'AMM à étudier par le Comité Technique des Spécialités Pharmaceutiques du 13/10/2021.
Pour ce comité technique, l’ordre de passage des dossiers sera comme suit .
Spécialités Pharmaceutiques fabriquées localement :
* Produits déjà évalués lors des derniers Comités Techniques
N° | Médicament | DCI | Dosage | Forme Pharmaceutique | Présentation | TITULAIRE | VEIC | Type de demande | DATE Rapport |
1 | CIAPLUS | TADALAFIL | 5 mg | Comprimé pelliculé | B/30 | ADWYA | C | N | 19/05/2021 |
* Produits à évaluer pour la première fois au Comité Technique
N° | Médicament | DCI | Dosage | Forme Pharmaceutique | Présentation | TITULAIRE | VEIC | Type de demande | DATE Rapport |
1 | LIDOCAÏNE 2% MEDIS AVEC ADRENA | ADRENALINE+ LIDOCAINE | Solution injectable | B/25 carpules /1.8 ml | LES LABORATOIRES MEDIS | E | N | 08/09/2021 | |
2 | DAIVODERM | CALCIPOTRIOL+BETAMETHASONE | 50 mcg/0.5mg/g | Gel dermique | FL/30 g | SIMED | E | N | 17/09/2021 |
3 | DAIVODERM | CALCIPOTRIOL+BETAMETHASONE | 50 mcg/0.5mg/g | Pommade dermique | T/30 g | SIMED | E | N | 17/09/2021 |
4 | VILDAMET | VILDAGLIPTINE+METFORMINE | 50 mg/1000 mg | Comprimé pelliculé | B/30 | PHILADELPHIA PHARMA | E | N | 29/09/2021 |
5 | ESTRADO | ESTRADIOL | 1 mg | Comprimé pelliculé | B/28 | LINO PHARMA | E | N | 30/09/2021 |
6 | ESTRADO | ESTRADIOL | 2 mg | Comprimé pelliculé | B/28 | LINO PHARMA | E | N | 30/09/2021 |
7 | MYCOPHIL | TERBINAFINE | 1% | Creme dermique | T/15 GR | GALPHARMA | E | V | 01/10/2021 |
Spécialités Pharmaceutiques importées
* Produits déjà évalués lors des derniers Comités Techniques
N° | Médicament | DCI | Dosage | Forme Pharmaceutique | Présentation | TITULAIRE | VEIC | Type de demande | date du courrier |
1 | PRILIGY | DAPOXETINE | 30 mg | COMP PL | B/3 | MENARINI Ind.Farmaceutiche Riunite SRL | V | N | 25/05/2021 |
2 | PRILIGY | DAPOXETINE | 60 mg | COMP PL | B/3 | MENARINI Ind.Farmaceutiche Riunite SRL | V | N | 25/05/2021 |
3 | SEROQUEL XL | QUETIAPINE | 50 MG | COMP LP | B/60 | ASTRA ZENECA UK | E | V | 31/05/2021 |
4 | SEROQUEL XL | QUETIAPINE | 400 MG | COMP LP | B/60 | ASTRA ZENECA UK | E | V | 31/05/2021 |
5 | SEROQUEL XL | QUETIAPINE | 300 MG | COMP LP | B/60 | ASTRA ZENECA UK | E | V | 31/05/2021 |
6 | SEROQUEL XL | QUETIAPINE | 200 MG | COMP LP | B/60 | ASTRA ZENECA UK | E | V | 31/05/2021 |
7 | RANEXA | RANOLAZINE | 750 mg | COMP LP | B/60 | Menarini International Operation Luxembourg S.A | E | N | 01/06/2021 |
8 | RANEXA | RANOLAZINE | 500 mg | COMP LP | B/60 | Menarini International Operation Luxembourg S.A | E | N | 01/06/2021 |
9 | SUXAMETHONIUM CHLORID VUAB | SUXAMETHONIUM | 100 mg | PDRE PR SUSP INJ | B/1FL | VUAB PHARMA AS | V | N | 02/06/2021 |
10 | LUCENTIS | RANIBIZUMAB | 10MG/ML | SOL INJ | B/1FL | NOVARTIS PHARMA | E | V | 02/06/2021 |
11 | ARCHIFAR | MEROPENEME | 1 GR | PDRE PR SOL INJ | B/1FL | MEDOCHEMIE CHYPRE | N | E | 15/06/2021 |
12 | ARCHIFAR | MEROPENEME | 0,5 GR | PDRE PR SOL INJ | B/1FL | MEDOCHEMIE CHYPRE | N | E | 15/06/2021 |
13 | LEUPRO-SANDOZ DÉPOT 1 MOIS | LEUPRORELINE | 3.6 mg | SERINGUE PRE REML | B/1 | Sandoz Pharma GmbH Allemagne | N | V | 22/06/2021 |
14 | LEUPRO-SANDOZ DÉPOT 3 MOIS | LEUPRORELINE | 5 mg | SERINGUE PRE REML | B/1 | Sandoz Pharma GmbH Allemagne | N | V | 22/06/2021 |
15 | TARGINACT | OXYCODONE+NALOXONE | 40mg/20mg | COMP LP | B/56 | Napp Pharmaceuticals Limited | V | N | 13/07/2021 |
16 | TARGINACT | OXYCODONE+NALOXONE | 10mg/5mg | COMP LP | B/56 | Napp Pharmaceuticals Limited | V | N | 13/07/2021 |
17 | TARGINACT | OXYCODONE+NALOXONE | 20mg/10mg | COMP LP | B/56 | Napp Pharmaceuticals Limited | V | N | 13/07/2021 |
18 | BRINTELLIX | VORTIOXETINE | 10 mg | COMP PEL | B/28 | H.LUNDBECK A/S | E | N | 30/07/2021 |
19 | TARKA FORTE | VERAPAMIL+ TRANDOLAPRIL | 240 MG/4MG | COMPRIME PELLICULE | B/28 | ABBOT-TURQUIE | E | N | 05/08/2021 |
20 | TARKA | VERAPAMIL+ TRANDOLAPRIL | 180 MG/2MG | COMPRIME PELLICULE | B/28 | ABBOT-TURQUIE | E | N | 05/08/2021 |
21 | RILUZOLE MYLAN 50 | RILUZOLE | 50 mg | COMP PEL | B/56 | MYLAN S.A.S | E | N | 18/08/2021 |
22 | CLARISCAN | MEGLUMINE GODATERATE | 0.5mmol/ml | SOL INJ | B/10FL/15 ML | GE HEALTHCARE AS NORVEGE | E | N | 18/08/2021 |
23 | CLARISCAN | MEGLUMINE GODATERATE | 0.5mmol/ml | SOL INJ | B/10FL/10 ML | GE HEALTHCARE AS NORVEGE | E | N | 18/08/2021 |
24 | CLARISCAN | MEGLUMINE GODATERATE | 0.5mmol/ml | SOL INJ | B/10FL/20 ML | GE HEALTHCARE AS NORVEGE | E | N | 18/08/2021 |
25 | ZAVICEFTA | CEFTAZIDIME+AVIBACTAM | 2g/0.5g | PDRE PR PREP INJ | B/10FL | PFIZER Ireland Pharmaceuticals | N | 02/09/2021 | |
26 | CORYZALIA | ALLIUM CEPA+BELLADONA... | SOL BUV | B/20 unidoses/1ml | BOIRON | C | N | 08/09/2021 | |
27 | GRANOCYTE | LENOGRASTIM | 34 MIL UI/ML | PDRE PR PREP INJ | B/5FL | SANOFI AB | V | N | 15/09/2021 |
28 | SIMULECT | BASILIXIMAB | 20 mg | PDRE PR PREP INJ | B/1FL | NOVARTIS PHARMA SCHWEIZ AG | V | N | 23/09/2021 |
29 | CETROTIDE | CETRORELIX | 0.25 MG | PDRE PR PREP INJ | B/1FL | MERCK EUROPE B.V | E | N | 23/09/2021 |
30 | DROPERIDOL AGUETTANT | DROPERIDOL | 1.25 mg/ml | SOL INJ | B/10AMP | AGUETTANT | E | N | 04/10/2021 |
* Produits à évaluer pour la première fois au Comité Technique
N° | Médicament | DCI | Dosage | Forme Pharmaceutique | Présentation | TITULAIRE | VEIC | Type de la demande | DATE RE |
1 | HUMIRA | ADALIMUMAB | 80 mg | SOL INJ | B/1 stylo pré-rempli/0.8 ml | ABBVIE DEUTSCHLAND Gmbh and Co.KG | E | N | 27/04/2021 |
2 | HUMIRA | ADALIMUMAB | 40 mg | SOL INJ | B/2stylo pré-rempli/0.4 ml | ABBVIE DEUTSCHLAND Gmbh and Co.KG | E | N | 27/04/2021 |
3 | HUMIRA | ADALIMUMAB | 20 mg | SOL INJ | B/2SERINGUE/0,2ML | ABBVIE DEUTSCHLAND Gmbh and Co.KG | E | N | 27/04/2021 |
4 | PANTONIX | PANTOPRAZOLE | 40 MG | PDRE PR PREP INJ | B/1FL | JULPHAR | E | N | 17/05/2021 |
5 | CEFODOX | CEFPODOXIME PROXETIL | 100 MG | COMP PEL | B/10 | PHARMA INTERNATIONAL COMPANY | E | V | 19/05/2021 |
6 | CEFODOX | CEFPODOXIME PROXETIL | 200 MG | COMP PEL | B/10 | PHARMA INTERNATIONAL COMPANY | E | V | 19/05/2021 |
7 | PEMZEK PLUS | CANDESARTAN+HYDROCHLOROTHIAZIDE | 8/12,5 MG | COMP PEL | B/28 | ASTRAZENECA SUISSE | E | T | 21/05/2021 |
8 | PEMZEK PLUS | CANDESARTAN+HYDROCHLOROTHIAZIDE | 16/12,5 MG | COMP PEL | B/28 | ASTRAZENECA SUISSE | E | T | 21/05/2021 |
9 | OVITRELLE | GONADOTROPHINE CHORIONIQUE | 250 MCG/0.5ml | SERINGUE | B/1 /0.5ml | MERCK EUROPE B.V | E | T | 31/05/2021 |
10 | DYMISTA | CHLORHYDRATE D'AZELASTINE+PROPIONATE DE FLUCTICASONE | 137 microgrammes / 50 microgra | Susp oral | B/1FL | MEDA PHARMA | I | N | 28/05/2021 |
11 | BETOPTIC | BETAXOLOL | 0.5% | Collyre | FL/5ML | NOVARTIS PHARMA NV | E | N | 28/05/2021 |
12 | MAXITROL | DEXAMETHASONE+NEOMYCINE+POLYMYXINE B | Collyre | FL/5 ML | NOVARTIS PHARMA SCHWEIZ AG | E | N | 28/05/2021 | |
13 | TRIMBOW | BECLOMETHASONE+FORMOTEROL+GLYCOPYRRONIUM | 87 µg/5 µg/9 µg | SOL PR INH | FL/120 doses | CHIESI FARMACEUTICI S.p.A | E | N | 28/05/2021 |
14 | FLUCON | FLUOROMETHOLONE | 0.1% | Collyre | FL/5ML | NOVARTIS PHARMA NV | E | N | 28/05/2021 |
15 | MYCAMINE | MICAFUNGINE | 50 MG | PDRE PR SOL PR PERFUSION | B/ 1FL/10ML | ASTELLAS PHARMA EUROPE B.V HOLLANDE | E | N | 28/05/2021 |
16 | MYCAMINE | MICAFUNGINE | 100 MG | PDRE PR SOL PR PERFUSION | B/ 1FL/10ML | ASTELLAS PHARMA EUROPE B.V HOLLANDE | E | N | 28/05/2021 |
17 | DEGAS | SIMETHICONE | 40mg/ml | EMULSION ORALE | B/1FL | AMMAN PHARMACEUTICAL INDUSTRIES | I | N | 24/06/2021 |
18 | SKYRIZI | RISANKIZUMAB | 75 mg | SOL INJ | B/2SERINGUE | ABBVIE DEUTSCHLAND Gmbh and Co.KG | N | 06/07/2021 | |
19 | AVENOC | PRODUITS HOMEOPATHIQUES | POMMADE RECTALE | T/30 G | BOIRON FRANCE | C | V | 15/06/2021 | |
20 | HOMEOVOX | SOUCHES HOMEOPATHIQUES | CP DRAGEIFIE | B/40 | BOIRON FRANCE | V | 12/07/2021 | ||
21 | STODAL | SOUCHES HOMEOPATHIQUES | SIROP | FL/200 ML | BOIRON FRANCE | V | 13/07/2021 | ||
22 | UN-ALFA | ALFACALCIDOL | 1 µG | CAPSULE | B/30 | CHEPLAPHARM Arzneimittel GmbH | E | T | 14/07/2021 |
23 | UN-ALFA | ALFACALCIDOL | 0,25 µG | CAPSULE | B/30 | CHEPLAPHARM Arzneimittel GmbH | E | T | 14/07/2021 |
24 | ESMERON | ROCURONIUM BROMURE | 50 mg/5ml | SOL INJ | B/10 | MERCK SHARP & DOHME BV | T | 14/07/2021 | |
25 | CEFODOX | CEFPODOXIME PROXETIL | 40 MG/5ML | PDRE PR SUSP ORALE | FL/100 | PHARMA INTERNATIONAL COMPANY | E | V | 29/07/2021 |
26 | GONAL-F | FSH | 75 UI (5.5 mcg) | PDRE PR PREP INJ | B/1 | MERCK EUROPE B.V | E | T | 16/08/2021 |
27 | UN-ALFA | ALFACALCIDOL | 1 µG | SOL INJ | B/10 AMP | CHEPLAPHARM Arzneimittel GmbH | E | T | 18/08/2021 |
28 | NASONEX | MOMETASONE | 50 MCG/DOSE | Susp NASAL | FL/140 DOSES | ORGANON TECHNIKA FRANCE | E | T | 09/08/2021 |
29 | ERBITUX 500 | CETUXIMAB | 5 mg/ml | SOL INJ PR PERFUSION | B/1 Flacon/ 100 ml | MERCK EUROPE B.V | V | T | 17/08/2021 |
30 | ERBITUX 100 | CETUXIMAB | 5 mg/ml | SOL INJ PR PERFUSION | B/1 Flacon/ 20 ml | MERCK EUROPE B.V | V | T | 17/08/2021 |
31 | PENTASA | MESALAZINE | 4 g | GRANULES LP | B/50 sachets | FERRING GmbH | V | N | RE 20/08/2021 |
32 | CADUET | AMLODIPINE+ATORVASTATINE | 10 mg/10 mg | COMP PEL | B/30 | PFIZER PFE FRANCE | E | T | 07/09/2021 |
33 | CADUET | AMLODIPINE+ATORVASTATINE | 5 mg/10 mg | COMP PEL | B/30 | PFIZER PFE FRANCE | E | T | 07/09/2021 |
34 | TAHOR | ATORVASTATINE | 80 mg | COMP PEL | B/28 | E | T | 13/09/2021 | |
35 | ICAZ LP | ISRADIPINE | 2.5 mg | GELULES LP | B/30 | Laboratorio Farmaceutico SIT S.r.l. | E | T | 16/09/2021 |
36 | NICOPATCHLIB | NICOTINE | 21 mg/24H | DISPOSITIF TRANSDERMIQUE | B/7 | PIERRE FABRE MEDICAMENT | C | N | RE 23/09/2021 |
37 | NICOPATCHLIB | NICOTINE | 7MG/24H | DISPOSITIF TRANSDERMIQUE | B/7 | PIERRE FABRE MEDICAMENT | C | N | RE 23/09/2022 |
38 | NICOPATCHLIB | NICOTINE | 14 mg/24h | DISPOSITIF TRANSDERMIQUE | B/7 | PIERRE FABRE MEDICAMENT | C | N | RE 23/09/2023 |
39 | NICOPATCHLIB | NICOTINE | 21 mg/24H | DISPOSITIF TRANSDERMIQUE | B/28 | PIERRE FABRE MEDICAMENT | C | N | RE 23/09/2024 |
40 | NICOPATCHLIB | NICOTINE | 14 mg/24H | DISPOSITIF TRANSDERMIQUE | B/28 | PIERRE FABRE MEDICAMENT | C | N | RE 23/09/2025 |
41 | NICOPATCHLIB | NICOTINE | 7 MG/24H | DISPOSITIF TRANSDERMIQUE | B/28 | PIERRE FABRE MEDICAMENT | C | N | RE 23/09/2026 |
42 | EFEXOR.XL | VENLAFAXINE | 150 mg | GELULES LP | B/28 | Upjohn UK Limited | E | T | 28/09/2021 |